SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4.28 |
| Enterprise Value ($M) | 3.18 |
| Book Value ($M) | 2.06 |
| Book Value / Share | 1.29 |
| Price / Book | 2.07 |
| NCAV ($M) | 2.06 |
| NCAV / Share | 1.29 |
| Price / NCAV | 2.07 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.27 |
| Return on Assets (ROA) | -0.78 |
| Return on Equity (ROE) | -0.98 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.98 |
| Current Ratio | 3.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.75 |
| Assets | 2.75 |
| Liabilities | 0.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.01 |
| Operating Income | -4.81 |
| Net Income | -4.68 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -4.97 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | MSD Partners, L.P. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,234 | 15,547 | 7.94 | |
| 4,688 | 24,030 | 19.51 | |
| 14,251 | 84,266 | 16.91 | |
| 17,231 | 87,094 | 19.78 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SXTC – China SXT Pharmaceuticals, Inc. | SXTP – 60 Degrees Pharmaceuticals, Inc. |
| SYBX – Synlogic, Inc. | TELO – Telomir Pharmaceuticals, Inc. |
| TENX – Tenax Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io